白细胞介素-17A对脓毒症小鼠肝肾损伤及预后的影响
该研究将84只SPF雄性C57BL/6小鼠随机分为假手术组、盲肠结扎穿孔(CLP)脓毒症模型组和IL-17A干预组(0.25、0.5、1、2、4 μg五个亚组),于术后即刻腹腔注射相应剂量IL-17A 100 μL或磷酸缓冲液100 μL。结果显示1 μg IL-17A组7天生存率最高(75.0%),故后续以1 μg为干预条件。与CLP组相比,1 μg IL-17A可显著延缓脓毒症早期各指标上升趋势,降低24小时ALT、AST、BUN、SCr、12小时IL-17A、IL-6、IL-10、24小时TNF-α及7天肝、肾病理评分和7天外周血、脾组织菌落数(均P<0.05)。作者认为适当剂量(1 μg)外源性IL-17A可减轻CLP诱导的致死性炎症反应、提高细菌清除能力,从而减轻肝肾损伤并改善脓毒症小鼠7天生存率。
要点
- 1 μg IL-17A干预组7天生存率最高(75.0%),据此选为后续干预条件。
- 与CLP组相比,1 μg IL-17A组24小时ALT 166.95±5.20 U/L vs. 271.30±6.11 U/L、AST 599.42±7.25 U/L vs. 1 013.27±3.37 U/L,均P<0.05。
- 1 μg IL-17A组24小时BUN 815.4±26.3 mg/L vs. 1 191.2±39.4 mg/L、SCr 29.34±0.87 μmol/L vs. 60.75±3.83 μmol/L,均P<0.05。
- 1 μg IL-17A组7天肝病理评分2.50(2.00, 3.00)vs. 9.00(8.50, 9.00)、肾病理评分1.00(1.00, 2.00)vs. 5.00(4.50, 5.00),均P<0.05。
- 1 μg IL-17A组7天外周血菌落数600(400, 600)CFU/mL vs. 4 200(4 200, 4 300)CFU/mL、脾组织菌落数4 600(4 400, 4 600)CFU/g vs. 23 400(23 200, 23 500)CFU/g,均P<0.05。
适用人群与场景
- SPF级雄性C57BL/6小鼠,共84只,用于生存率观察及后续指标检测。
诊断标准与关键阈值
- 脓毒症模型采用盲肠结扎穿孔(CLP)法诱导。
处置流程与药物剂量
- IL-17A干预组于术后即刻腹腔注射相应剂量IL-17A(0.25、0.5、1、2、4 μg)100 μL;其余组腹腔注射磷酸缓冲液(PBS)100 μL。
- 根据7天生存率选择1 μg IL-17A作为后续研究的干预条件。
研究设计与关键结果
- 研究类型为动物实验;84只SPF雄性C57BL/6小鼠随机分为假手术组、CLP组和IL-17A干预组(0.25、0.5、1、2、4 μg五个亚组)。
- 除假手术组外,1 μg IL-17A干预组7天生存率最高(75.0%),故选定该条件用于后续研究。
- 与假手术组相比,CLP组术后各时间点肝肾功能显著受损:ALT、AST、BUN、SCr于术后24小时达峰,肝、肾病理评分于术后7天达峰,炎性细胞因子IL-17A、IL-6、IL-10于术后12小时达峰,TNF-α于术后24小时达峰;外周血和脾组织大量细菌增殖,于第7天达峰。
- 与CLP组相比,外源性给予1 μg IL-17A显著延缓脓毒症早期各指标上升趋势:24小时ALT(U/L)166.95±5.20 vs. 271.30±6.11,24小时AST(U/L)599.42±7.25 vs. 1 013.27±3.37,24小时BUN(mg/L)815.4±26.3 vs. 1 191.2±39.4,24小时SCr(μmol/L)29.34±0.87 vs. 60.75±3.83,7天肝病理评分2.50(2.00, 3.00)vs. 9.00(8.50, 9.00),7天肾病理评分1.00(1.00, 2.00)vs. 5.00(4.50, 5.00),12小时IL-17A(ng/L)105.21±0.31 vs. 111.28±1.37,12小时IL-6(ng/L)83.22±1.01 vs. 108.88±0.99,12小时IL-10(ng/L)731.54±
证据类型、等级与局限
- 证据类型:动物实验(小鼠CLP脓毒症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为适当剂量(1 μg)外源性IL-17A可减轻CLP诱导的致死性炎症反应、提高细菌清除能力,从而减轻肝肾损伤并改善脓毒症小鼠7天生存率;该结论来自小鼠实验,原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the effect of interleukin-17A (IL-17A) on liver and kidney injury and prognosis in septic mice.
METHODS: A total of 84 SPF male C57BL/6 mice were randomly divided into sham operation group (Sham group), cecal ligation and puncture (CLP) induced sepsis model group (CLP group), and IL-17A intervention group. IL-17A intervention group were then divided into five subgroups according to the dose of IL-17A (0.25, 0.5, 1, 2, 4 μg). Mice in the IL-17A intervention group were intraperitoneally injected with the corresponding dose of IL-17A 100 μL immediately after surgery. The other groups were intraperitoneally injected with 100 μL phosphate buffer solution (PBS). The survival rate of mice was observed at 7 days, and peripheral blood and liver, kidney and spleen tissues were collected. According to the 7-day survival, another 18 mice were randomly divided into Sham group, CLP group, and 1 μg IL-17A intervention group. Peripheral blood samples were collected at 12 hours and 24 hours after CLP, and the mice were sacrificed to obtain liver, kidney, and spleen tissues. The behavior and abdominal cavity of each group were observed. The levels of peripheral blood liver and kidney function indexes and inflammatory factors were detected. The histopathological changes of liver and kidney were observed under light microscope. The peripheral blood and spleen tissues were inoculated in the medium, the number of bacterial colonies was calculated, and the bacterial migration of each group was evaluated in vitro.
RESULTS: Except for the Sham group, the 7-day survival rate of mice in the 1 μg IL-17A intervention group was the highest (75.0%), so this condition was selected as the intervention condition for the subsequent study. Compared with Sham group, the liver and kidney functions of CLP group were significantly damaged at each time point after operation. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN) and serum creatinine (SCr) reached the peak at 24 hours after operation, and the liver and kidney pathological scores reached the peak at 7 days after operation, the levels of inflammatory cytokines interleukin (IL-17A, IL-6, IL-10) reached the peak at 12 hours after operation, and tumor necrosis factor-α (TNF-α) reached the peak at 24 hours after operation. In addition, a large number of bacteria proliferated in the peripheral blood and spleen, which reached the peak on day 7. Compared with the CLP group, exogenous administration of 1 μg IL-17A significantly delayed the rising trend of each index in the early stage of sepsis [24-hour ALT (U/L): 166.95±5.20 vs. 271.30±6.11, 24-hour AST (U/L): 599.42±7.25 vs. 1 013.27±3.37, 24-hour BUN (mg/L): 815.4±26.3 vs. 1 191.2±39.4, 24-hour SCr (μmol/L): 29.34±0.87 vs. 60.75±3.83, 7-day liver pathological score: 2.50 (2.00, 3.00) vs. 9.00 (8.50, 9.00), 7-day kidney pathological score: 1.00 (1.00, 2.00) vs. 5.00 (4.50, 5.00), 12-hour IL-17A (ng/L): 105.21±0.31 vs. 111.28±1.37, 12-hour IL-6 (ng/L): 83.22±1.01 vs. 108.88±0.99, 12-hour IL-10 (ng/L): 731.54±3.04 vs. 790.25±2.54, 24-hour TNF-α (μg/L): 454.67±0.66 vs. 576.18±0.76, 7-day peripheral blood colony count (CFU/mL): 600 (400, 600) vs. 4 200 (4 200, 4 300), 7-day spleen tissue colony count (CFU/g): 4 600 (4 400, 4 600) vs. 23 400 (23 200, 23 500), all P < 0.05].
CONCLUSIONS: Appropriate dose (1 μg) of exogenous IL-17A can reduce the lethal inflammatory response induced by CLP and improve the ability of bacterial clearance, thereby alleviating liver and kidney injury and improving the 7-day survival rate of septic mice.
参考来源
- Liang Y, Guan C, Meng H, et al. [Effects of interleukin-17A on liver and kidney injury and prognosis in septic mice]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37366124. doi:10.3760/cma.j.cn121430-20230110-00011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。